Massachusetts General HospitalBoston, MA, United States
Disclosure information not submitted.
3619 - Determinants of Chemosensory Dysfunction after Treatment for Nasopharyngeal Carcinoma: A Multi-Institutional Prospective Cohort Study
Wednesday, October 2, 202410:30 AM – 11:45 AM ET